Goldman Sachs Group Inc Pacific Biosciences Of California, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,238,267 shares of PACB stock, worth $8.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,238,267

Previous 3,982,565 6.42%

Holding current value

$8.35 Million

Previous $5.46 Million 32.06%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.2 - $2.17 $306,842 - $554,873	255,702 Added 6.42%	4,238,267 $7.21 Million
Q2 2024 Aug 13, 2024	BUY	$1.36 - $3.65 $2.42 Million - $6.48 Million	1,776,559 Added 80.53%	3,982,565 $5.46 Million
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $2.16 Million - $5.9 Million	614,899 Added 38.65%	2,206,006 $8.27 Million
Q4 2023 Feb 13, 2024	SELL	$5.97 - $10.36 $610,647 - $1.06 Million	-102,286 Reduced 6.04%	1,591,107 $15.6 Million
Q3 2023 May 14, 2024	BUY	$8.23 - $13.93 $841,813 - $1.42 Million	102,286 Added 6.43%	1,693,393 $14.1 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $6.32 Million - $10.7 Million	-768,448 Reduced 31.21%	1,693,393 $14.1 Million
Q2 2023 May 14, 2024	BUY	$9.97 - $14.05 $1.42 Million - $2 Million	142,549 Added 6.15%	2,461,841 $32.7 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $1.42 Million - $2 Million	142,549 Added 6.15%	2,461,841 $32.7 Million
Q1 2023 May 14, 2024	SELL	$7.94 - $12.02 $1.75 Million - $2.65 Million	-220,869 Reduced 8.7%	2,319,292 $26.9 Million
Q1 2023 May 11, 2023	SELL	$7.94 - $12.02 $1.75 Million - $2.65 Million	-220,869 Reduced 8.7%	2,319,292 $26.9 Million
Q4 2022 May 14, 2024	SELL	$5.67 - $11.2 $6.32 Million - $12.5 Million	-1,115,284 Reduced 30.51%	2,540,161 $20.8 Million
Q4 2022 Feb 13, 2023	SELL	$5.67 - $11.2 $6.32 Million - $12.5 Million	-1,115,284 Reduced 30.51%	2,540,161 $20.8 Million
Q3 2022 May 14, 2024	SELL	$3.93 - $8.57 $18.8 Million - $41 Million	-4,783,127 Reduced 56.68%	3,655,445 $21.2 Million
Q3 2022 Nov 10, 2022	SELL	$3.93 - $8.57 $18.8 Million - $41 Million	-4,783,127 Reduced 56.68%	3,655,445 $21.2 Million
Q2 2022 May 14, 2024	BUY	$4.02 - $10.43 $27.5 Million - $71.4 Million	6,847,465 Added 430.36%	8,438,572 $37.3 Million
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $22.2 Million - $57.7 Million	5,533,953 Added 190.52%	8,438,572 $37.3 Million
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $1.93 Million - $4.79 Million	228,964 Added 8.56%	2,904,619 $26.4 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $5.97 Million - $9.32 Million	309,978 Added 13.1%	2,675,655 $54.7 Million
Q3 2021 Nov 10, 2021	BUY	$24.86 - $35.02 $58.8 Million - $82.8 Million	2,365,677 New	2,365,677 $60.4 Million

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Pacific Biosciences Of California, Inc. Transaction History